Richard R. Duffy Joins Core Informatics As Director of Customer Success
News Jan 11, 2014
Core Informatics, a leading provider of data management solutions to clients engaged in scientific research, has hired Richard R. Duffy to serve as Director of Customer Success. In this new role, Richard will be responsible for professional services, support and customer satisfaction, ensuring that Core Informatics customers realize differentiated value from the best of breed Core Informatics platform to meet their unique business needs.
"Richard has excelled in every aspect of enterprise software development and solution delivery," said Josh Geballe, CEO of Core Informatics. "We are delighted to add his over 20 years of experience implementing a broad range of enterprise technology solutions for Fortune 500 companies to our executive team. Our clients will benefit from his experience and commitment to their success and satisfaction."
Most recently Richard was Director of Product Development at Fiserv, where he led the deployment and support of their payment platform that processed millions of payments per month. In this leadership role he worked closely with cross functional teams at Sunoco, Hewlett Packard, Walmart, and Kroger to ensure that technology is leveraged effectively to meet business goals and drive rapid ROI.
"I am very excited to join the Core Informatics team. Focusing on the successful implementation of the Core platform for each and every customer is imperative to our success," said Richard. "I look forward to working with our customers to help them achieve their goals using our unique, fully web-based and highly configurable technology."
Scientists at Tokyo Tech, Ricoh co. and The National Institute of Advanced Industrial Science and Technology have developed an ultra-low-power atomic clock (ULPAC) for small satellites to enable future communication systems beyond 5G. The proposed device outperforms the current industry standards in various benchmarks, such as size, stability, and power consumption.
With their ability to treat a wide a variety of diseases, spherical nucleic acids are poised to revolutionize medicine. But before these digitally designed nanostructures can reach their full potential, researchers need to optimize their various components. A team has developed a direct route to optimize these particles, bringing them one step closer to becoming a viable treatment option for numerous diseases, including cancer.READ MORE